Michael Amoroso, the President and CEO of Precision BioSciences Inc . (NASDAQ:DTIL), has recently sold shares in the company. According to a filing with the Securities and Exchange Commission, Amoroso ...

Dario Scimeca, General Counsel and Secretary of Precision BioSciences Inc . (NASDAQ:DTIL), a biotechnology company with a market capitalization of $38 million and currently trading at $4.97, executed ...

Precision BioSciences Inc (DTIL) stock saw a modest uptick, ending the day at $5.7 which represents a slight increase of $1.20 or 26.67% from the prior close of $4.5. The stock opened at $6.8 and ...

DURHAM, N.C., January 09, 2025--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

BMO Capital Markets upgraded shares of Precision BioSciences (NASDAQ:DTIL – Free Report) from a market perform rating to an outperform rating in a report released on Friday, Marketbeat Ratings reports ...

HC Wainwright reiterated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note issued to investors on Friday,Benzinga reports. HC Wainwright currently has ...